Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus
- 1 December 2002
- Vol. 21 (3-4) , 202-210
- https://doi.org/10.1016/s0264-410x(02)00456-5
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequenciesJournal of Hepatology, 1999
- Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis CHepatology, 1998
- Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatmentJournal of Hepatology, 1996
- Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.Journal of Clinical Investigation, 1995
- T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infectionsHepatology, 1994
- Randomised trial of lymphoblastoid α-interferon in chronic hepatitis C: Effects on inflammation, fibrogenesis and viremiaJournal of Hepatology, 1993
- Peptides Naturally Presented by MHC Class I MoleculesAnnual Review of Immunology, 1993
- Immune Response in Mice that Lack the Interferon-γ ReceptorScience, 1993
- Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.The Journal of Experimental Medicine, 1992
- Insights on the amino acid side-chain interactions of a synthetic T-cell determinantBiologicals, 1991